Billionaire Loeb Sold Shares in AI Leaders, Boosts AI Stock
In quarterly 13F disclosures, billionaire loeb sold shares of major AI players while adding to a smaller AI stock tha...
Using Indices As Performance Benchmarks: An overview of why and how investors use indices as performance yardsticks to measure success.
17,026 articlesIn quarterly 13F disclosures, billionaire loeb sold shares of major AI players while adding to a smaller AI stock tha...
Could buying sweetgreen stock be a gateway to lasting wealth, or is it a risky turnaround bet? This guide cuts throug...
Ray Dalio argues we are in stage five of the big cycle, signaling rising debt, widening inequality, and geopolitical ...
Tilray Brands is expanding beyond its cannabis roots into beverages and other segments. This article examines whether...
As Assertio prepares to discuss its Q4 2025 results, investors look for clues about product performance, margins, and...
A cliff-like Medicare IRMAA rule makes a tiny annual income step cost retirees hundreds more each month. This report ...
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Money stories outlive bank balances. Learn to tell yours clearly, protect loved ones, and build a legacy that reflect...
EWJ has fallen 9% in the past 30 days while Japan’s economy rides on fragile oil supply lines. The shift tests the op...
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
As the broad market declines, three oil and gas ETFs stay in the green, illustrating how energy exposure can act as a...
A venture-backed biotech startup unveils a plan to collect genomic data from 100 million species to fuel AI drug disc...